Related Experiment Video
Updated: May 16, 2026

Rapid In Vivo Assessment of Adjuvant's Cytotoxic T Lymphocytes Generation Capabilities for Vaccine Development
Published on: June 19, 2018
Immunogenicity, safety and tolerability of vaccinations in premature infants
Susanna Esposito1, Monica Fumagalli, Nicola Principi
1Pediatric Clinic 1, Department of Pathophysiology and Transplantation, Università degli Studi di Milano, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy. susanna.esposito@unimi.it
Insights
Premature infants (PIs) have developing immune systems, making them vulnerable to infections. PIs should follow standard infant vaccination schedules, regardless of birth weight or prematurity, for optimal protection.
Area of Science:
- Pediatrics
- Immunology
- Vaccinology
Background:
- Neonates and young children exhibit functionally impaired immune defenses, leading to increased susceptibility and severity of infections.
- Premature infants (PIs) possess a more compromised immune system compared to full-term infants, increasing their risk of serious infectious complications.
- The severity of infectious issues in PIs correlates with the degree of prematurity.
Purpose of the Study:
- To review the characteristics of the developing immune system in early life.
- To analyze the impact of immune impairments on immunization efficacy in PIs.
- To evaluate the response, safety, and tolerability of vaccines in PIs.
Main Methods:
- Comprehensive literature review analyzing existing data on infant immunity and vaccination.
- Assessment of studies focusing on the immune response of premature infants to various vaccines.
- Evaluation of vaccine safety and tolerability profiles in the premature infant population.
Main Results:
- Data suggest that premature infants (PIs) can adhere to the standard vaccination schedule recommended for full-term infants.
- Vaccination schedules for PIs should not be adjusted for prematurity or birth weight.
- Current evidence supports the safety and tolerability of established vaccines in PIs.
Conclusions:
- Premature infants (PIs) should receive vaccinations according to the standard schedule without prematurity correction.
- Further research is essential to assess the efficacy and safety of newly approved and upcoming vaccines in PIs.
- Consistent vaccination practices are crucial for protecting PIs against preventable infectious diseases.
Abstract:
Infections are more common and generally more severe in neonates and young children than in older children and adults, mainly because immune defenses are functionally impaired in early life. The seriousness of the infectious problems of premature infants (PIs) is proportional to how premature they are, but irrespective of this, they are more serious than those of full-term infants because their immune system is compromised to a greater extent. This review analyzes our knowledge of the characteristics of the developing immune system, the impact of possible impairments on immunization, the real response of PIs to vaccines and the safety and tolerability of different vaccines. Overall, the data indicate that PIs should follow the same vaccination schedule as that generally used for full-term infants, without correcting for prematurity and regardless of birthweight. However, there is an urgent need for further studies concerning the use of recently marketed vaccines and those that will be marketed in the near future.
Related Concept Videos
Development of Immunocompetence
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
Vaccinations
Immunological Memory
What is Immunological Memory?
Immunological memory is an integral function of the immune system that allows it to recognize and react more rapidly and effectively to pathogens previously encountered. This feature is...
Vaccines
Microorganisms in Medicine and Therapeutics

